Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination.
about
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients.Tracking Cefoperazone/Sulbactam Resistance Development In vivo in A. baumannii Isolated from a Patient with Hospital-Acquired Pneumonia by Whole-Genome SequencingPharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis.Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.Determination of cefoperazone and sulbactam in serum by HPLC-MS/MS: An adapted method for therapeutic drug monitoring in children.
P2860
Q35299177-C131B55D-8185-4F97-8FDF-F660419C2285Q35305116-A818A575-4931-4C7E-97D8-1DBD57F3C4F4Q37188148-0F5B710C-0989-4B6C-BE7C-D3A266ED407BQ39817477-51B526FA-DD35-4821-8F51-F3ECF1C528ACQ44013965-D70FC3FF-24F7-4E97-AAC9-8C240FD4FBCDQ47687534-DFFE3F92-E693-4429-A6E7-9ABD64B8836BQ47792817-77D06A7D-2A6B-44ED-9870-87FCFF7A48EC
P2860
Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Multiple-dose pharmacokinetics ...... ngle agents or in combination.
@en
Multiple-dose pharmacokinetics ...... ngle agents or in combination.
@nl
type
label
Multiple-dose pharmacokinetics ...... ngle agents or in combination.
@en
Multiple-dose pharmacokinetics ...... ngle agents or in combination.
@nl
prefLabel
Multiple-dose pharmacokinetics ...... ngle agents or in combination.
@en
Multiple-dose pharmacokinetics ...... ngle agents or in combination.
@nl
P2093
P2860
P356
P1476
Multiple-dose pharmacokinetics ...... ngle agents or in combination.
@en
P2093
P2860
P356
10.1128/AAC.32.1.42
P407
P577
1988-01-01T00:00:00Z